(Q33495493)

27 July 2017

1 reference

title

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy (English)

1 reference

27 July 2017

1 reference

C Bokemeyer

1

1 reference

27 July 2017

M A Kuczyk

2

1 reference

27 July 2017

H Köhne

3

1 reference

27 July 2017

H Einsele

4

1 reference

27 July 2017

B Kynast

5

1 reference

27 July 2017

H J Schmoll

6

1 reference

27 July 2017

publication date

1 January 1996

1 reference

27 July 2017

1 reference

27 July 2017

volume

72

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

1-9

1 reference

Treatment of testicular cancer: a new and improved model

27 July 2017

cites work

1 reference

12 December 2020

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

1 reference

12 December 2020

No growth-stimulation of heterotransplanted human testicular cancer cell-lines by recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf).

1 reference

12 December 2020

POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity

1 reference

12 December 2020

Use of granulocyte growth factors in solid tumours

1 reference

12 December 2020

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin

1 reference

12 December 2020

High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions

1 reference

12 December 2020

Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma

1 reference

12 December 2020

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

12 December 2020

The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients

1 reference

12 December 2020

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

1 reference

12 December 2020

[Successful collection of peripheral blood stem cells mobilized by high-dose etoposide for patients with chemotherapy-resistant and/or poor prognostic testicular cancer]

1 reference

12 December 2020

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

1 reference

12 December 2020

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study

1 reference

12 December 2020

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

12 December 2020

Hematologic neoplasia associated with primary mediastinal germ-cell tumors

1 reference

12 December 2020

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

12 December 2020

High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study

1 reference

12 December 2020

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

12 December 2020

Hemopoietins in clinical oncology

1 reference

12 December 2020

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

12 December 2020

Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin

1 reference

12 December 2020

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

12 December 2020

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial

1 reference

12 December 2020

BOP/VIP - A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours

1 reference

12 December 2020

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa

1 reference

12 December 2020

Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells

1 reference

12 December 2020

Growth factors in haematology: prophylactic versus interventional use.

1 reference

12 December 2020

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis

1 reference

12 December 2020

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

12 December 2020

Side-effects of GM-CSF treatment in advanced testicular cancer

1 reference

12 December 2020

Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy

1 reference

12 December 2020

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit

1 reference

12 December 2020

Treatment of poor-risk germ-cell tumors with high-dose cisplatin and etoposide combined with bleomycin

1 reference

12 December 2020

"Poor-risk" germ cell tumors: current progress and future directions

1 reference

12 December 2020

Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines

1 reference

12 December 2020

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

1 reference

12 December 2020

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer

1 reference

12 December 2020

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma

1 reference

12 December 2020

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

1 reference

12 December 2020

Cultured cell lines from human teratomas: windows into tumour growth and differentiation and early human development

1 reference

12 December 2020

Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002770050128

1 reference

27 July 2017

1 reference